NL-OMON20896尚未招募不适用
PILOT TRIAL IN TYPE 2 DIABETES MELLITUS PATIENTS TO EXPLORE NEW FINGERPRINTS AND FUNCTIONAL MARKERS DURING START AND STOP OF REGULAR PHARMACOLOGICAL GLUCOSE LOWERING TREATMENT AS ADD-ON TO NEW COMPOUND PHASE 1 STUDIES
no sponsor0 个研究点目标入组 30 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
研究概览
简要总结
/A
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Diabetes Mellitus type 2 patients eligible to start wash-out as per criteria in new compound studies
排除标准
- 未提供
研究者
相似试验
已完成
3 期
Open Trial of Miglitol in Type 2 Diabetic Patients Treated With BiguanideType 2 Diabetes MellitusNCT00334503Sanwa Kagaku Kenkyusho Co., Ltd.
已完成
3 期
Double-Blind Trial of Miglitol in Type 2 Diabetic Patients Treated With BiguanideType 2 Diabetes MellitusNCT00334399Sanwa Kagaku Kenkyusho Co., Ltd.
已完成
3 期
Double-Blind Trial of Miglitol in Type 2 Diabetic Patients With Insulin TreatmentType 2 Diabetes MellitusNCT00213070Sanwa Kagaku Kenkyusho Co., Ltd.
进行中（未招募）
2 期
A Series of Pilot Studies to Evaluate the haemoDynamic and mEtabolic Effects oF apelIn aNd rElaxinCardiovascular DiseasesType 2 Diabetes MellitusNCT03449251Cambridge University Hospitals NHS Foundation Trust170
招募中
1 期
Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes IIPlatelet AggregationAspirinPlatelet Aggregation InhibitorsType 2 DiabetesDiabetes Mellitus, Type 2NCT05702463Montreal Heart Institute30